American Society of Transplantation and Cellular Therapy series 4: Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation
Transplantation and Cellular Therapy
; : 2666-6367, 20210915.
Artigo
em Inglês
| BIGG - guias GRADE
| ID: biblio-1292237
Biblioteca responsável:
BR1.1
ABSTRACT
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A new approach was employed with the goal of better serving clinical providers by publishing each standalone topic in the infectious diseases series as a concise format of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious diseases and HCT content experts developed and answered FAQs. Topics were finalized with harmonized recommendations that were made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. The fourth topic in the series focuses on the management and treatment of cytomegalovirus (CMV) resistant and refractory infections. The diagnosis, definitions of resistant and refractory CMV, risk factors, virological genotypes and treatment algorithms are reviewed.
Texto completo:
Disponível
Coleções:
Bases de dados temática
Base de dados:
BIGG - guias GRADE
Assunto principal:
Infecções por Citomegalovirus
/
Transplante de Células-Tronco Hematopoéticas
/
Citomegalovirus
Tipo de estudo:
Estudo diagnóstico
/
Guia de prática clínica
/
Fatores de risco
Idioma:
Inglês
Revista:
Transplantation and Cellular Therapy
Ano de publicação:
2021
Tipo de documento:
Artigo
Instituição/País de afiliação:
Fred Hutchinson Cancer Research Centre/US
/
Memorial Sloan Kettering Cancer Center/US
/
Sungkyunkwan University School of Medicine/KR
/
University of MD Anderson Cancer Centre/US
/
University of Melbourne/AU
/
University of Texas MD Anderson Cancer Centre/US